Thus, some of the recommendations in Part II are based on a strong theoretical rationale and suggestive evidence in the absence of confirmatory scientific knowledge. Finally, some of the infection control practices routinely used by surgical teams cannot be rigorously studied for ethical or logistical reasons (e.g., wearing vs not wearing gloves). This is especially true regarding the implementation of SSI prevention measures. By necessity, available studies have often been conducted in narrowly defined patient populations or for specific kinds of operations, making generalization of their findings to all specialties and types of operations potentially problematic. However, there are a limited number of studies that clearly validate risk factors and prevention measures for SSI. Part II, “Recommendations for Prevention of Surgical Site Infection,” represents the consensus of the Hospital Infection Control Practices Advisory Committee (HICPAC) regarding strategies for the prevention of SSIs.3 Whenever possible, the recommendations in Part II are based on data from well-designed scientific studies. Included is a detailed discussion of the pre-, intra-, and postoperative issues relevant to SSI genesis. This two-part guideline updates and replaces previous guidelines.1 and 2 Part I, “Surgical Site Infection: An Overview,” describes the epidemiology, definitions, microbiology, pathogenesis, and surveillance of SSIs. Such patients include those who have had chemoradiotherapy and need reconstructive surgery, and patients from lower and middle-income countries and from poorer communities in high income countries who often have high levels of co-morbidity because of resource constraints.ĮXECUTIVE SUMMARYThe “Guideline for Prevention of Surgical Site Infection, 1999” presents the Centers for Disease Control and Prevention (CDC)’s recommendations for the prevention of surgical site infections (SSIs), formerly called surgical wound infections.
Needed in the selection and duration of antibiotic prophylaxis.Įxpert commentary: Head and neck surgeons should give personalized care, especially to Several risk factors for SSIs need to be considered to reduce future rates, and care is also Impacts on patients’ subsequent activities and their quality of life, which is exacerbated by SSIs. Consequently, SSIs need to be avoided where possible, as even the surgery itself SSIs can lead to delayed wound healing, increased morbidity and mortality as wellĪs costs. Postoperative wound infections, termed ‘surgical site infections’ (SSIs) are a significant impediment to head and neck cancer surgery and recovery, and need to be addressed.Īreas Covered: Approximately 10-45% of patients undergoing head-and-neck cancers surgeryĭevelop SSIs.
Introduction: Surgery in patients with head and neck cancers is frequently complicated by multiple stages of procedure that includes significant surgical removal of all or part of an organ with cancer, tissue reconstruction, and extensive neck dissection.
0 kommentar(er)
